Summary
The staphylococcal cell-wall protein known as protein A has been explored as a therapeutic modality in the treatment of cancer and allied diseases. Protein A binds the Fc fragment of IgG 1,2 and 4, and preferentially binds to IgG incorporated into immune complexes. Early investigators focused on the immune-suppressive effects of immune complexes in cancer and, based on in vitro experiments, postulated that clearance of immune complexes in vivo would permit effective immune clearance of cancer cells. A large clinical trial of the perfusion of cancer patient plasma over protein A was subsequently undertaken. Results were generally disappointing, with no complete remissions and overall response rates of 22%. Response rates for Kaposi's sarcoma (39%) and breast adenocarcinoma (26%) were somewhat encouraging, and further clinical trials in these disorders are ongoing. More impressive have been the responses to protein A perfusion in immune thrombocytopenia and hemolytic-uremic syndrome. Using a protein A-silica device, Snyder et al. reported responses in 42% of immune thrombocytopenia patients, with mean increases in platelet count from 27×109/l to 120×109/l. On the basis of these results, the protein A-silica column was approved by the United States Food and Drug Administration for treatment of immune thrombocytopenia. Equally encouraging are reports of an overall 59% response rate in cancer chemotherapy-related hemolytic-uremic syndrome. Reported toxicities include fever, chills, hypotension, dyspnea and musculoskeletal pain. With rare exceptions, these reactions are easily treated and do not result in cessation of therapy. Unfortunately, the mechanism of action of plasma perfusion over protein A is very unclear. The best available evidence would point to an immunomodulatory role, manifested by stimulation of an anti-idiotype response in immune thrombocytopenia. A better understanding of how protein A immunoadsorption alters the immune response will be necessary to permit optimum use of this therapy.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Ciavarella D, Mittelman A, Zang E, Reiss RF, Platelet function abnormalities following plasma perfusion over protein A-silica in cancer patients. Prog Clin Biol Res 283:607, 1988
Gjörstrup P, Watt RM, Therapeutic protein A immunoadsorption: a review. Transfus Sci 11:281, 1990
Handelsman H, Protein A columns for the treatment of patients with idiopathic thrombocytopenic purpura and other indications. Health Technology Assessment Report No. 7. Agency for Health Care Policy and Research, Public Health Service, US Department of Health and Human Services, 1990
Jones JV, Staphylococcal protein A as an extracorporeal immunosorbent: theoretical and practical considerations. Transfus Sci 11: 153, 1990
Jones FR, Yoshida LH, Ladiges WC, Treatment of feline leukemia and reversal of Fe LV by ex vivo removal of IgG. Cancer 46: 675, 1980
Kinet J-P, Bensinger WI, Frankenne F, Hennen G, Faoidart J, Mahieu P, Immunoadsorption with staphylococcal protein A in human neoplasms. In: Pineda AA (ed) Selective plasma component removal. Futura, Mount Kisco, pp 105–137, 1984
McDougal JS, Redecha PB, Inman RD, Christian CL, Binding of immunoglobulin G aggregates and immune complexes in human sera to staphylococcal containing protein A. J Clin Invest 63: 627, 1979
Messerschmidt GL, Henry DH, Snyder HW, Jr, Bertram J, Mittelman A, Ainsworth S, Fiore J, Viola MV, Louie J, Ambinder E, MacKintosh FR, Higby DJ, O'Brien Kiprov D, Hamburger M, Balint JP, Fisher LD, Perkins W, Pinsky CM, Jones FR, Protein A immunoadsorption in the treatment of malignant disease. J Clin Oncol 6:203, 1988
Messerschmidt GL, Henry DH, Snyder HW Jr, Bertram J, Mittelman A, Ainsworth S, Fiore J, Viola MV, Louie J, Ambinder E, MacKintosh FR, Higby DJ, O'Brien P, Kiprov D, Hamburger M, Balint JP, Fisher LD, Perkins W, Pinsky CM, Jones FR, Protein A immunotherapy in the treatment of cancer: an update. Semin Hematol 26 [Suppl 1]: 19, 1989
Mittelman A, Bertram J, Henry DH, Snyder HW Jr, Messerschmidt GL, Ciavarella D, Ainsworth S, Kiprov D, Arlin Z, Treatment of patients with HIV thrombocytopenia and hemolytic uremic syndrome with protein A (Prosorba column) immunoadsorption. Semin Hematol 26 [Suppl 1]: 15, 1989
Nand S, Molokie R, Therapeutic plasmapheresis and protein A immunoadsorption in malignancy. J Clin Apheresis 5: 206, 1990
Snyder HW Jr., Jones FR, Day NK, Selective removal of antigen-complexed IgG from cat plasma by adsorption onto a protein A-silica matrix. J Immunol Methods 101: 209, 1987
Snyder HW Jr. Balint JP, Jones FR, Modulation of immunity in patients with autoimmune disease and cancer treated by extracorporeal immunoadsorption with Prosorba columns. Semin Hematol 26 [Suppl 1]: 31, 1989
Snyder HW Jr, Cochran SK, Reed DE, Balint JP, Jones FR, and Prosorba Clinical Trial Group, Treatment of immune thrombocytopenia, cancer and cancer chemotherapy associated thrombotic thrombocytopenic purpura/hemolytic uremic syndrome with protein A immunoadsorption (abstract). J Clin Apheresis 5: 169, 1990
Snyder HW Jr, Henry DH, Messerschmidt GL, Mittelman A, Bertram J, Ambinder E, Kiprov D, Balint JP, MacKintosh FR, Hamberger M, O'Brien P, Ainsworth S, Fisher LD, Perkins W, Jones FR, Minimal toxicity during protein A immunoadsorption treatment of malignant disease: an outpatient therapy. J Clin Apheresis 6:1, 1991
Snyder HW Jr, Mittelman A, Messerschmidt GL, Henry DH, Korec S, Ciavarella D, Bertram JH, Guthrie TH, Wuest D, Oral A, Balint JP, Cockran SK, Jones FR, Treatment of cancer chemotherapy-associated hemolytic uremic syndrome by protein A immunoadsorption of plasma. Cancer (in press)
Terman DS, Young JB, Shearer WT, Ayus C, Lehane D, Mattioli C, Espada R, Howell JF, Yamamoto T, Zaleski HT, Miller L, Fromme P, Feldman L, Henry JF, Tillquist R, Cook G, Daskal Y, Preliminary observations of effects on breast adenocarcinoma of plasma perfusion over immobilized protein A. N Engl J Med 305: 1195, 1981
Wuest D, Ciavarella D, McCroskey A, Mittelman A, Thrombosis associated with protein A immunoadsorption (abstract). J Clin Apheresis 5:165, 1990
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ciavarella, D. The use of protein A columns in the treatment of cancer and allied diseases. Int J Clin Lab Res 21, 210–213 (1992). https://doi.org/10.1007/BF02591648
Issue Date:
DOI: https://doi.org/10.1007/BF02591648